Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China
· Delayed Price · Currency is CNY 7.63
+0.09 (1.19%)
Mar 10, 2026, 3:04 PM CST
SHE:002550 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 439.28 | 439.95 | 576.23 | 409.26 | 617.81 | 516.11 | Upgrade
|
| Short-Term Investments | - | 192.9 | 64.95 | - | - | - | Upgrade
|
| Trading Asset Securities | 610.44 | 273.83 | 71.98 | 67.48 | 68.23 | 234.28 | Upgrade
|
| Cash & Short-Term Investments | 1,050 | 906.67 | 713.16 | 476.73 | 686.03 | 750.39 | Upgrade
|
| Cash Growth | 48.16% | 27.13% | 49.59% | -30.51% | -8.58% | -13.35% | Upgrade
|
| Accounts Receivable | 280.4 | 274.25 | 275.52 | 632.87 | 447.67 | 461.88 | Upgrade
|
| Other Receivables | 22.12 | 23.24 | 16.9 | 2.48 | 2.56 | 4.81 | Upgrade
|
| Receivables | 302.52 | 297.48 | 292.42 | 635.35 | 450.23 | 466.69 | Upgrade
|
| Inventory | 382.97 | 426.81 | 602.01 | 536.48 | 400.63 | 315.97 | Upgrade
|
| Prepaid Expenses | - | - | - | - | 0.01 | 0.01 | Upgrade
|
| Other Current Assets | 202.23 | 62.73 | 18.39 | 38.72 | 33.04 | 23.96 | Upgrade
|
| Total Current Assets | 1,937 | 1,694 | 1,626 | 1,687 | 1,570 | 1,557 | Upgrade
|
| Property, Plant & Equipment | 547.36 | 563.6 | 561.27 | 616.39 | 611.77 | 599.56 | Upgrade
|
| Long-Term Investments | 96.84 | 160.08 | 203.22 | 156.78 | 40.56 | 6.71 | Upgrade
|
| Goodwill | 11.14 | 11.14 | 11.14 | 11.14 | 11.14 | 11.14 | Upgrade
|
| Other Intangible Assets | 108 | 109.32 | 113.14 | 100.86 | 106.92 | 114.42 | Upgrade
|
| Long-Term Deferred Tax Assets | 57.99 | 75.26 | 90.53 | 101.49 | 99.42 | 105.52 | Upgrade
|
| Long-Term Deferred Charges | 162.19 | 138.04 | 93.77 | 60.33 | 46.85 | 38.14 | Upgrade
|
| Other Long-Term Assets | 94.52 | 15.3 | 3.05 | 71.67 | 21.81 | 19.27 | Upgrade
|
| Total Assets | 3,015 | 2,830 | 2,766 | 2,806 | 2,508 | 2,452 | Upgrade
|
| Accounts Payable | 59.29 | 88.64 | 41.18 | 45.97 | 71.23 | 106.25 | Upgrade
|
| Accrued Expenses | 27.23 | 88.06 | 89.7 | 101.94 | 99.55 | 96.63 | Upgrade
|
| Short-Term Debt | - | 21.49 | 56.31 | 103.05 | 93.56 | 41.85 | Upgrade
|
| Current Income Taxes Payable | 12.51 | 1.53 | 0.64 | 0.05 | - | 15.02 | Upgrade
|
| Current Unearned Revenue | 5.33 | 9.68 | 9.71 | 15.58 | 19.67 | 11.86 | Upgrade
|
| Other Current Liabilities | 59.34 | 14 | 8.28 | 11.63 | 12.34 | 19.38 | Upgrade
|
| Total Current Liabilities | 163.71 | 223.39 | 205.81 | 278.22 | 296.35 | 290.98 | Upgrade
|
| Long-Term Unearned Revenue | 88.44 | 86.46 | 81.85 | 89.35 | 93.42 | 94.87 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.71 | 4.02 | 4.52 | 4.96 | 0.47 | 0.5 | Upgrade
|
| Total Liabilities | 255.86 | 313.87 | 292.17 | 372.53 | 390.24 | 386.35 | Upgrade
|
| Common Stock | 1,280 | 1,280 | 1,280 | 1,280 | 1,280 | 1,280 | Upgrade
|
| Additional Paid-In Capital | 41.42 | 41.65 | 41.65 | 36.29 | 29.38 | 25.58 | Upgrade
|
| Retained Earnings | 1,603 | 1,369 | 1,163 | 1,134 | 960.89 | 929.79 | Upgrade
|
| Treasury Stock | -170.86 | -170.86 | -30.09 | - | -145.05 | -154.38 | Upgrade
|
| Comprehensive Income & Other | -2.02 | -2.42 | 0.36 | -0.06 | 2.23 | -0.88 | Upgrade
|
| Total Common Equity | 2,751 | 2,517 | 2,455 | 2,450 | 2,127 | 2,080 | Upgrade
|
| Minority Interest | 8.77 | -0.87 | 18.98 | -16.95 | -9.09 | -14.56 | Upgrade
|
| Shareholders' Equity | 2,760 | 2,517 | 2,474 | 2,433 | 2,118 | 2,065 | Upgrade
|
| Total Liabilities & Equity | 3,015 | 2,830 | 2,766 | 2,806 | 2,508 | 2,452 | Upgrade
|
| Total Debt | - | 21.49 | 56.31 | 103.05 | 93.56 | 41.85 | Upgrade
|
| Net Cash (Debt) | 1,050 | 885.19 | 656.85 | 373.69 | 592.48 | 708.54 | Upgrade
|
| Net Cash Growth | 52.46% | 34.76% | 75.78% | -36.93% | -16.38% | 35.81% | Upgrade
|
| Net Cash Per Share | 0.83 | 0.70 | 0.51 | 0.29 | 0.49 | 0.59 | Upgrade
|
| Filing Date Shares Outstanding | 1,250 | 1,250 | 1,275 | 1,280 | 1,280 | 1,280 | Upgrade
|
| Total Common Shares Outstanding | 1,250 | 1,250 | 1,275 | 1,280 | 1,280 | 1,280 | Upgrade
|
| Working Capital | 1,774 | 1,470 | 1,420 | 1,409 | 1,274 | 1,266 | Upgrade
|
| Book Value Per Share | 2.20 | 2.01 | 1.93 | 1.91 | 1.66 | 1.63 | Upgrade
|
| Tangible Book Value | 2,632 | 2,397 | 2,331 | 2,338 | 2,009 | 1,954 | Upgrade
|
| Tangible Book Value Per Share | 2.11 | 1.92 | 1.83 | 1.83 | 1.57 | 1.53 | Upgrade
|
| Buildings | - | 498.75 | 498.75 | 525.73 | 524.28 | 448.65 | Upgrade
|
| Machinery | - | 568.44 | 558.3 | 504.84 | 461.29 | 426.63 | Upgrade
|
| Construction In Progress | - | 61.25 | 8.19 | 54.1 | 39.24 | 76.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.